Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688399's Quick Ratio is ranked worse than 53.12% of 1412
companies
in the Biotechnology industry
Industry Median: 3.595
vs SHSE:688399: 3.25
Jiangsu Bioperfectus Technologies Co (SHSE:688399) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Jiangsu Bioperfectus Technologies Co Quick Ratio Related Terms
Jiangsu Bioperfectus Technologies Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Bioperfectus Technologies Co Quick Ratio Chart
SHSE:688399 vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, Jiangsu Bioperfectus Technologies Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangsu Bioperfectus Technologies Co Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jiangsu Bioperfectus Technologies Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Jiangsu Bioperfectus Technologies Co's Quick Ratio falls into.
Jiangsu Bioperfectus Technologies Co Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Bioperfectus Technologies Co (SHSE:688399) has a Quick Ratio of 3.25 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Jiangsu Bioperfectus Technologies Co and its competitors. This is 23% below median its historical median of 4.20. Over the past decade, Jiangsu Bioperfectus Technologies Co's Quick Ratio has ranged from 2.41 to 9.25. According to the industry distribution chart, Jiangsu Bioperfectus Technologies Co ranks #750 out of 1412 companies in the Biotechnology industry, placing it in the top 53.1%.
Is Jiangsu Bioperfectus Technologies Co's Quick Ratio too high?
Jiangsu Bioperfectus Technologies Co's current Quick Ratio of 3.25 is 23% below median its 10-year median of 4.20. Over the past 10 years, this metric has ranged from a low of 2.41 to a high of 9.25. The Biotechnology industry median Quick Ratio is 3.60. Jiangsu Bioperfectus Technologies Co's value of 3.25 is 9.6% below this industry median. Based on the distribution chart, Jiangsu Bioperfectus Technologies Co ranks #750 out of 1412 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Jiangsu Bioperfectus Technologies Co has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Bioperfectus Technologies Co's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Jiangsu Bioperfectus Technologies Co ranks #750 out of 1412 companies for Quick Ratio. This places Jiangsu Bioperfectus Technologies Co in the lower half of its industry. The industry median Quick Ratio is 3.60. Jiangsu Bioperfectus Technologies Co's value of 3.25 is 9.6% below this benchmark. Historically, Jiangsu Bioperfectus Technologies Co's own Quick Ratio has ranged from 2.41 to 9.25 over the past decade. While the company's 10-year median is 4.20 vs. the industry median of 3.60, Jiangsu Bioperfectus Technologies Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,412 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangsu Bioperfectus Technologies Co's current Quick Ratio of 3.25 is 9.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Jiangsu Bioperfectus Technologies Co and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Bioperfectus Technologies Co's current Quick Ratio is 3.25, which is 23% below median its own 10-year median of 4.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Bioperfectus Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Bioperfectus Technologies Co (SHSE:688399) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.93, compared to a current price of ¥29.89 — trading 3.3% above its estimated fair value. The current Quick Ratio is 3.25, which is 23% below median its 10-year median of 4.20 and 9.6% below the Biotechnology industry median of 3.60. Jiangsu Bioperfectus Technologies Co's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Jiangsu Bioperfectus Technologies Co (SHSE:688399), the current Quick Ratio is 3.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangsu Bioperfectus Technologies Co (SHSE:688399) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangsu Bioperfectus Technologies Co stock appears to be overvalued.
The current stock price of ¥29.89 is trading 3.3% above its estimated GF Value™ of ¥28.93.
GuruFocus considers Jiangsu Bioperfectus Technologies Co to be Fairly Valued.
Key valuation signals for SHSE:688399:
Quick Ratio: 3.25 (23% below median its 10-year median of 4.20)
GF Value™: ¥28.93 vs. price of ¥29.89 (3.3% above fair value)
Industry Position: 9.6% below the Biotechnology median (#750 of 1412)
No single metric tells the full story. See the SHSE:688399 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangsu Bioperfectus Technologies Co Business Description
Jiangsu Bioperfectus Technologies Co Ltd is engaged in product development, production and sales of disease prevention and control, female genital micro-ecological testing and tumor screening. Its products portfolio includes Fever respiratory pathogen detection series, Fever with a rash pathogen test series, Fever with bleeding pathogen test series, Foodborne diseases and diarrheal pathogen detection and Other types of pathogen detection series.
63GF Score
Get the complete analysis for SHSE:688399
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688399 has been successfully added to your 
